Safer Viruses for Vaccine Research and Diagnosis

A 3D reconstruction of a chimeric viral particle. Proteins on the virus surface have been coloured using a rainbow gradient to represent the many possible viruses that could be presented using this system. This image, and all of the project's visualizations, were developed by UQ's Dr. Daniel Watterson. Courtesy of Dr. Daniel Watterson

A new technology to produce safer 'hybrid' viruses at high volumes for use in vaccines and diagnostics for mosquito-borne diseases has been developed at The University of Queensland.

Researchers from UQ and QIMR Berghofer Medical Research Institute have exploited the benign characteristics of the Binjari virus -- inert to humans -- to produce 'dangerous looking' mosquito-borne viruses such as Zika and dengue, but which cannot grow in humans or animals.

The School of Chemistry and Molecular Biosciences' Dr. Jody Hobson-Peters said the team, led by professor Roy Hall, began to explore this possibility after discovering new viruses in the lab.

"We were originally hoping to gain insights into how mosquito-borne viral diseases evolve - viruses like Zika, yellow fever and dengue," Hobson-Peters said. "We were also hoping to discover new viruses that might be useful for biotechnology or as biological control agents. The Binjari virus stood out, and while it grows to very high levels in mosquito cells in the lab, it's completely harmless and cannot infect humans or other vertebrate species. And it is incredibly tolerant for genetic manipulation, allowing us to swap important genes from pathogenic viruses like Zika, West Nile and dengue into the Binjari genome. This produces hybrid, or chimeric, viruses that physically appeared identical to the disease-causing viruses under the electron microscope, but were still unable to grow in human or animal cells."

The researchers have effectively developed a new biotechnology platform requiring low biocontainment, to help safely develop vaccines and diagnostics against these mosquito-borne diseases.

Professor Andreas Suhrbier, from QIMR Berghofer Medical Research Institute, said the team hoped to push this technology further down the development pathway toward human applications.

"The main advantage of this system is that it is safe," Suhrbier said. "These hybrids cannot infect humans, meaning that manufacture of vaccines and diagnostic reagents don't require the strict and expensive biosecurity infrastructure ordinarily needed to grow these pathogenic viruses. The research is a testament to collaborative science - this all fell into place, with amazing collaboration within the Australian Infectious Diseases Research Centre. It's a technology that will truly revolutionise the manufacture of vaccines - supercharging high-volume vaccine development."

The research has been published in Science Translational Medicine (DOI: 10.1126/scitranslmed.aax7888).

Source: University of Queensland

4 Comments on "Safer Viruses for Vaccine Research and Diagnosis"

  1. 583720 251120Average In turn sends provides is the frequent systems that give the opportunity for ones how does a person pick-up biological, overdue drivers, what 1 mechanically increases the business. Search Engine Marketing 909853

  2. 995114 71382Hello! I just wish to give an enormous thumbs up for the excellent information you might have proper here on this post. I can be coming again to your blog for a lot more soon. 724869

  3. 74422 549896Youre so cool! I dont suppose Ive read anything in this way before. So good to locate somebody by original thoughts on this topic. realy thanks for beginning this up. this fabulous internet site is one thing that is needed on the internet, a person with a bit of originality. beneficial project for bringing a new challenge towards internet! 70931

  4. 976646 333082The digital cigarette makes use of a battery and a small heating element the vaporize the e-liquid. This vapor can then be inhaled and exhaled 750650

Leave a comment

Your email address will not be published.


*